AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
RPRX vs AMZN Fundamental Comparison
| Metric | RPRX | AMZN |
|---|---|---|
| Revenue | $2.4B | $716.9B |
| Net Income | $770.9M | $77.7B |
| Net Margin | 32.4% | 10.8% |
| ROE | 7.9% | 18.9% |
| ROA | 3.9% | 9.5% |
| Current Ratio | 2.40x | 1.05x |
| Debt/Equity | 0.92x | 0.17x |
| EPS | $1.78 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RPRX vs AMZN: Frequently Asked Questions
Is RPRX or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. RPRX is rated HOLD (75% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does RPRX compare to AMZN fundamentally?
Royalty Pharma plc has ROE of 7.9% vs AMAZON COM INC's 18.9%. Net margins are 32.4% vs 10.8% respectively.
Which stock pays higher dividends, RPRX or AMZN?
RPRX has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RPRX or AMZN for long term?
For long-term investing, consider that RPRX has HOLD rating with 75% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RPRX vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RPRX vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.